Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity
about
Nanotoxicology - a pathologist's perspectiveMulti-walled carbon nanotubes: sampling criteria and aerosol characterizationPulmonary inflammation after intraperitoneal administration of ultrafine titanium dioxide (TiO2) at rest or in lungs primed with lipopolysaccharideA biocompatible medium for nanoparticle dispersionInhalation exposure to carbon nanotubes (CNT) and carbon nanofibers (CNF): methodology and dosimetryToxicological evaluation of lung responses after intratracheal exposure to non-dispersed titanium dioxide nanorodsComparison of the biological activity between ultrafine and fine titanium dioxide particles in RAW 264.7 cells associated with oxidative stressEvaluating the toxicity of airborne particulate matter and nanoparticles by measuring oxidative stress potential - a workshop report and consensus statementEffect of multi-walled carbon nanotube surface modification on bioactivity in the C57BL/6 mouse modelEffects of nickel-oxide nanoparticle pre-exposure dispersion status on bioactivity in the mouse lungToxicity of nanomaterialsNo time to lose--high throughput screening to assess nanomaterial safetyInhalation of silver nanomaterials--seeing the risksImplications of in vitro dosimetry on toxicological ranking of low aspect ratio engineered nanomaterialsImplementation of alternative test strategies for the safety assessment of engineered nanomaterialsBiological response to nano-scale titanium dioxide (TiO2): role of particle dose, shape, and retentionPhysicochemical properties of nanomaterials: implication in associated toxic manifestationsAerosolized ZnO nanoparticles induce toxicity in alveolar type II epithelial cells at the air-liquid interfaceRole of engineered metal oxide nanoparticle agglomeration in reactive oxygen species generation and cathepsin B release in NLRP3 inflammasome activation and pulmonary toxicityIn Vivo Toxicity Studies of Metal and Metal Oxide NanoparticlesToxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects.Detecting the oxidative reactivity of nanoparticles: a new protocol for reducing artifactsStable nanoparticle aggregates/agglomerates of different sizes and the effect of their size on hemolytic cytotoxicity.A standardised approach for the dispersion of titanium dioxide nanoparticles in biological media.The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles.Synthesis of Carbohydrate Capped Silicon Nanoparticles and their Reduced Cytotoxicity, In Vivo Toxicity, and Cellular Uptake.Toxic and adjuvant effects of silica nanoparticles on ovalbumin-induced allergic airway inflammation in miceAlternative in vitro assays in nanomaterial toxicology.Ecotoxicity test methods for engineered nanomaterials: practical experiences and recommendations from the bench.Analytical approaches for the characterization and quantification of nanoparticles in food and beverages.The surfactant dipalmitoylphophatidylcholine modifies acute responses in alveolar carcinoma cells in response to low-dose silver nanoparticle exposure.The role of iron impurities in the toxic effects exerted by short multiwalled carbon nanotubes (MWCNT) in murine alveolar macrophages.Iron oxide nanoparticle agglomeration influences dose rates and modulates oxidative stress-mediated dose-response profiles in vitro.Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing.Relating the physicochemical characteristics and dispersion of multiwalled carbon nanotubes in different suspension media to their oxidative reactivity in vitro and inflammation in vivo.Toxicity of Nickel Oxide Nanoparticles on a Freshwater Green Algal Strain of Chlorella vulgaris.Induction thermal plasma process modifies the physicochemical properties of materials used for carbon nanotube production, influencing their cytotoxicity.Preparation of nanoparticle dispersions for in-vitro toxicity testing.Oxidative damage to Pseudomonas aeruginosa ATCC 27833 and Staphylococcus aureus ATCC 24213 induced by CuO-NPs.Exposure to Inorganic Nanoparticles: Routes of Entry, Immune Response, Biodistribution and In Vitro/In Vivo Toxicity Evaluation.
P2860
Q23909944-A3A8D772-9FDE-4E19-97BF-B09F25B13F12Q23910346-B6C1BEED-A5DD-4F63-9634-336B8E721365Q23910937-99745893-A3CE-42AD-965D-0A4FD62E9633Q23911518-DEA5A9B8-7612-4BE1-B0C7-E9363C23E904Q23913295-0B2CC38D-AF84-4672-92C2-724B4B7DD382Q23914725-05802952-E323-434A-9128-77DFCBB9F730Q23914896-0ECA56DD-31A2-452C-BDA6-D21799DD27DEQ23915341-196A9CB3-A11C-4DC1-944D-43FEE4EC0660Q23922858-6C8EB572-D92D-40B1-BCAB-0E15E84E5CFFQ23922862-A34AD30C-2416-4AFB-B224-A99B7F9A7BF4Q28383168-26DDF3BB-EFE0-4B7B-A18C-A1212EDDF781Q28383671-9A118022-BEC4-486C-BB1A-E278821BEC87Q28385452-12CF1F8B-B284-4057-830C-B364E070FFA2Q28389056-11B7E64E-ED2A-4F5F-8196-DE7A8612548FQ28390126-30343AAE-27B8-459F-8AE0-8D4A0327A6F9Q28390269-7B4E803F-D2B6-4DE2-AB06-0D009372ED52Q28392831-8944D8AB-9594-4434-B27D-66D5A55616F7Q28395846-AF219B78-C166-4C92-81D7-FFBF31E5AD42Q28950619-05100C2B-9034-4532-88C5-A8C23778205BQ28950905-2A991585-670E-496C-BA71-9ED4993980B7Q33867695-AB4E0281-030A-4211-B380-1880F43D7A3CQ33883177-BAB326B0-7DC7-4052-9D6B-8A730CCDB311Q34153916-61800299-CBFD-4499-9A21-8FA71F893A0AQ34187508-1631C2A1-700A-47C4-B167-59674C831EA8Q35583445-26E22068-B189-42F8-A4A8-3E6649D75C8FQ35677032-AE0D5405-3CEE-48B1-B9A7-DDD65F6813B2Q36911253-208E5D2F-CE68-44D5-A49C-C28ADE7620E2Q37902143-7FC171ED-2E3B-49E9-A718-70EFF41F345FQ37946275-3B321B08-DFF8-4E5F-AF66-B3FDC77FC902Q38815083-1558F952-6554-4004-B5C2-2482750187CDQ38886457-D284244A-8499-4FD6-92C8-E5E0958CD76DQ39067376-8CAF5999-B05F-44FA-AF23-F97D7BCD426CQ39128530-E65EFEE7-381D-4B6B-A7A6-40BBF80FA7C1Q39533187-2033BC49-E81B-4CF1-A032-B943554FF90EQ39663102-94701607-3686-4395-9C44-0A05551E5D96Q41986544-55CC6362-89C4-4797-B24B-034DB9ED062DQ42830415-63511AED-C8F4-4005-8032-6341A13C24C1Q43276373-3BD7AE58-EF3C-4B5A-BB74-287215484209Q46323706-7E655669-BFD8-49C3-A443-6B9D79DADE53Q47169890-34380274-4FD5-45AE-9EFB-F2FF824E9AF4
P2860
Improved method to disperse nanoparticles for in vitro and in vivo investigation of toxicity
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Improved method to disperse na ...... vivo investigation of toxicity
@ast
Improved method to disperse na ...... vivo investigation of toxicity
@en
Improved method to disperse na ...... vivo investigation of toxicity
@en-gb
type
label
Improved method to disperse na ...... vivo investigation of toxicity
@ast
Improved method to disperse na ...... vivo investigation of toxicity
@en
Improved method to disperse na ...... vivo investigation of toxicity
@en-gb
prefLabel
Improved method to disperse na ...... vivo investigation of toxicity
@ast
Improved method to disperse na ...... vivo investigation of toxicity
@en
Improved method to disperse na ...... vivo investigation of toxicity
@en-gb
P2093
P2860
P921
P3181
P1433
P1476
Improved method to disperse na ...... vivo investigation of toxicity
@en
P2093
Diane E. Schwegler-Berry
Tina M. Sager
Victor A. Robinson
William G. Lindsley
P2860
P2880
P304
P3181
P356
10.1080/17435390701381596
P577
2007-01-01T00:00:00Z